Wall Street analysts raised price targets for UnitedHealth Group following a technical recovery and dividend announcement.
JPMorgan Chase & Co. increased its target to $466. Truist Financial adjusted its target to $440. Mizuho set a new target of $460. All three firms maintained Buy or Outperform ratings.
The stock recently reclaimed key moving averages after a significant sell-off. UnitedHealth declared a quarterly dividend of $2.32 per share. The board cited substantial operating cash flow and financial health as drivers for the payout. Analysts view these factors as a compelling investment opportunity.